Nothing Special   »   [go: up one dir, main page]

MXPA04003540A - Utilizacion de un copolimero para producir una forma galenica que contiene un peptido o proteina como agente activo. - Google Patents

Utilizacion de un copolimero para producir una forma galenica que contiene un peptido o proteina como agente activo.

Info

Publication number
MXPA04003540A
MXPA04003540A MXPA04003540A MXPA04003540A MXPA04003540A MX PA04003540 A MXPA04003540 A MX PA04003540A MX PA04003540 A MXPA04003540 A MX PA04003540A MX PA04003540 A MXPA04003540 A MX PA04003540A MX PA04003540 A MXPA04003540 A MX PA04003540A
Authority
MX
Mexico
Prior art keywords
peptide
copolymer
protein
galenic form
produce
Prior art date
Application number
MXPA04003540A
Other languages
English (en)
Inventor
Beckert Thomas
Original Assignee
R Hm Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Hm Gmbh & Co Kg filed Critical R Hm Gmbh & Co Kg
Publication of MXPA04003540A publication Critical patent/MXPA04003540A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La invencion se relaciona con la utilizacion de un copolimero para la preparacion de una forma farmaceutica que contiene un peptido o proteina como un principio activo, asi como la forma farmaceutica que contiene un peptido o una proteina que es el principio activo, asi como se obtiene una forma farmaceutica de la mismo.
MXPA04003540A 2001-10-15 2001-10-15 Utilizacion de un copolimero para producir una forma galenica que contiene un peptido o proteina como agente activo. MXPA04003540A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2001/011899 WO2003032958A1 (de) 2001-10-15 2001-10-15 Verwendung eines copolymeren zur herstellung einer arzneiform, die als wirkstoff ein peptid oder protein enthält

Publications (1)

Publication Number Publication Date
MXPA04003540A true MXPA04003540A (es) 2004-07-22

Family

ID=8164626

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04003540A MXPA04003540A (es) 2001-10-15 2001-10-15 Utilizacion de un copolimero para producir una forma galenica que contiene un peptido o proteina como agente activo.

Country Status (12)

Country Link
US (1) US20030091637A1 (es)
EP (1) EP1435922A1 (es)
JP (1) JP2005506991A (es)
KR (1) KR20040047915A (es)
BR (1) BR0117149A (es)
CA (1) CA2460132A1 (es)
HU (1) HUP0401732A2 (es)
IL (1) IL160190A0 (es)
MX (1) MXPA04003540A (es)
PL (1) PL367957A1 (es)
SK (1) SK1732004A3 (es)
WO (1) WO2003032958A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04010956A (es) * 2003-01-30 2005-01-25 Roehm Gmbh Forma de dosis farmaceutica y metodo para la produccion de la misma.
US7094545B2 (en) * 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
DE10332160A1 (de) * 2003-07-15 2005-02-03 Röhm GmbH & Co. KG Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Peptid- oder Protein-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
DK1500390T3 (da) 2003-07-25 2005-09-19 Ferring Bv Farmaceutisk præparat som fast dosisform og fremgangsmåde til fremstilling deraf
CN1826099B (zh) * 2003-07-25 2010-06-09 凡林有限公司 固体剂型药物组合物及其制造方法
CA2490601C (en) * 2003-12-29 2006-05-02 Ferring B.V. Method for preparing solid dosage form of desmopressin
US7018653B2 (en) * 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
PT1550439E (pt) * 2003-12-29 2006-06-30 Ferring Bv Metodo para a preparacao de uma forma solida de dosagem de desmopressina
AU2006249100B2 (en) 2005-05-18 2012-01-19 Assistance Publique - Hospitaux De Paris Colonic delivery of adsorbents
DE102005024614A1 (de) * 2005-05-25 2006-11-30 Röhm Gmbh Verwendung von Polymermischungen zur Herstellung von überzogenen Arzneiformen sowie Arzneiform mit polymerem Mischüberzug
US8048413B2 (en) 2006-05-17 2011-11-01 Helene Huguet Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules
JP5524624B2 (ja) * 2007-11-16 2014-06-18 旭化成ケミカルズ株式会社 水系フィルムコーティング液、および、フィルムコーティング顆粒、ならびに、これを用いた錠剤
CN107205948B (zh) * 2015-01-29 2021-12-14 诺和诺德股份有限公司 包含glp-1激动剂和肠溶衣的片剂

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208465A (en) * 1978-05-03 1980-06-17 E. I. Du Pont De Nemours And Company Clear coat/color coat finish containing an antioxidant and an ultraviolet light stabilizer
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
DE3405378A1 (de) * 1984-02-15 1985-08-22 Röhm GmbH, 6100 Darmstadt Arzneimittelueberzug
DE3524337A1 (de) * 1985-07-08 1987-01-08 Roehm Gmbh Arzneimittelumhuellung
IT1230576B (it) * 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
US5032405A (en) * 1989-09-27 1991-07-16 Warner-Lambert Company Oral pharmaceutical composition for acid sensitive proteinaceous agents
DE4026992A1 (de) * 1990-08-25 1992-02-27 Roehm Gmbh Verfahren zur herstellung von traegersystemen fuer biologisch aktive materialien
ES2109362T3 (es) * 1991-06-21 1998-01-16 Univ Cincinnati Unas proteinas administrables oralmente y metodo para hacerlas.
EP0603992B2 (en) * 1992-12-22 2000-12-06 University Of Cincinnati Oral administration of immunologically active biomolecules and other therapeutic proteins
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
DE9414066U1 (de) * 1994-08-31 1994-11-03 Röhm GmbH & Co. KG, 64293 Darmstadt Überzugs- und Bindemittel für Arzneiformen sowie damit hergestellte Arzneiform
DE9414065U1 (de) * 1994-08-31 1994-11-03 Röhm GmbH & Co. KG, 64293 Darmstadt Thermoplastischer Kunststoff für darmsaftlösliche Arznei-Umhüllungen
DE19653606A1 (de) * 1996-12-20 1998-06-25 Roehm Gmbh Haft- und Bindemittel aus (Meth)acrylatpolymer, organischer Säure und Weichmacher
DE19715794C1 (de) * 1997-04-16 1998-12-03 Roehm Gmbh Laminare Arzneiform und Verfahren zu ihrer Herstellung
US20010026800A1 (en) * 2000-01-07 2001-10-04 Michael Jacob G. Selective activation of a TH1 or TH2 lymphocyte regulated immune response

Also Published As

Publication number Publication date
BR0117149A (pt) 2004-11-23
WO2003032958A1 (de) 2003-04-24
KR20040047915A (ko) 2004-06-05
CA2460132A1 (en) 2003-04-24
IL160190A0 (en) 2004-07-25
EP1435922A1 (de) 2004-07-14
US20030091637A1 (en) 2003-05-15
SK1732004A3 (sk) 2005-06-02
HUP0401732A2 (hu) 2004-12-28
JP2005506991A (ja) 2005-03-10
PL367957A1 (en) 2005-03-07

Similar Documents

Publication Publication Date Title
CA2411754A1 (en) 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoic acid and compositions for delivering active agents
IL152659A (en) Liquid pharmaceutical compositions comprising a pegylated human erythropoietin protein and a multiple charged inorganic anion, in a pharmaceutically acceptable buffer
MXPA03011041A (es) Composiciones farmaceuticas que contienen orlistat y acidos grasos y/o sales de los mismos.
EP1476138B8 (en) Modified release formulations of at least one form of tramadol
MXPA04003540A (es) Utilizacion de un copolimero para producir una forma galenica que contiene un peptido o proteina como agente activo.
WO2000055126A3 (en) N-cyanomethylamides as protease inhibitors
WO2002094210A3 (de) Kosmetische mittel
WO2000055124A3 (en) Novel compounds and compositions as protease inhibitors
UA88056C2 (uk) Дозована форма оксикодону, що вводиться один раз на день
EP0783299A4 (en) COMPOUNDS AND COMPOSITIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES
IL195055A0 (en) Phenoxy carboxylic acid compounds and compositions for delivering active agents
ATE311373T1 (de) Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
EP2308479A3 (en) Compounds and compositions for delivering active agents
WO2002015959A3 (en) Compounds and compositions for delivering active agents
WO2001068645A3 (en) N-cyanomethylcarboxamides and their use as protease inhibitors
AU2001291731A1 (en) Pharmaceutical, effervescent formulation containing ramipril
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
WO2002011740A3 (en) 'slow release' pharmaceutical compositions comprising lithium carbonate
BG108668A (en) Use of a copolymer to produce a galenic form containing a peptide or a protein as active agent
MXPA04004450A (es) Nuevos compuestos y composiciones como inhibidores de catepsina s.
WO2003002598A3 (en) Peptides for use as translocation factors
NZ521515A (en) Composition comprising paracetamol and niflumic acid
MXPA04006269A (es) Composicion farmaceutica que comprende un inhibidor de alfa-glucosidasa y acido 4-oxobutanoico y uso de la misma para tratamiento de diabetes.
EP1452522A3 (en) Novel compounds and compositions as protease inhibitors
TW200518749A (en) Stabilised pharmaceutical compositions